| Literature DB >> 35883030 |
Shuiquan Yang1, Weiping Yao2, James E Siegler3, Mohammad Mofatteh4, Jack Wellington5, Jiale Wu6,7, Wenjun Liang1, Gan Chen1, Zhou Huang8, Rongshen Yang6,7, Juanmei Chen9, Yajie Yang10, Zhaohui Hu11, Yimin Chen12.
Abstract
OBJECTIVE: We aimed to evaluate door-to-puncture time (DPT) and door-to-recanalization time (DRT) without directing healthcare by neuro-interventionalist support in the emergency department (ED) by workflow optimization and improving patients' outcomes.Entities:
Keywords: Door-to-puncture time; Door-to-recanalization time; Endovascular therapy; Ischemic stroke; Puncture-to-recanalization time; Workflow optimization
Mesh:
Year: 2022 PMID: 35883030 PMCID: PMC9315077 DOI: 10.1186/s12873-022-00692-8
Source DB: PubMed Journal: BMC Emerg Med ISSN: 1471-227X
A summary of improvement measures implemented with details provided for each measure
| Measures | Details |
|---|---|
| Chief of hospital engagement | The chief of the hospital was engaged in the introduction process of the measures to facilitate improving stroke workflow |
| Pre-notification | A pre-notification system was established via referral hospital doctors to communicate a history of patients from the next of kin and assess thrombectomy treatment benefits and risks for suspected ischemic large vessel occlusion patients |
| Training | Multiple training sessions were provided for stroke and emergency nurses to promptly recognize stroke signs and symptoms |
| Priority | Suspected ischemic stroke patients were prioritized for triage by an emergency doctor |
| CT was prioritized for suspected ischemic stroke patients | |
| CTA or MRA for suspected ischemic stroke large vessel occlusion patients within 24 h of onset was prioritized | |
| When CTA was performed, CTA images were reconstructed by radiologists in real-time to facilitate rapid imaging interpretation | |
| CT was primarily used for all patients, but MRI/MRA/CTP/MRP was prioritized for suspected ischemic stroke patients | |
| Neurointerventionalist availability for emergency procedures was prioritized for patients with intracranial occlusion | |
| Reduce procedures | Implementation of a modified direct-to-Digital Subtraction Angiography approach, bypassing CTA for selected patients with a clinical suspicion of large vessel occlusion and lack of intracranial hemorrhage on initial CT |
| More rapid acquisition of consent with support of other providers | |
| Neuro-interventionists team cooperation | Cooperation of two experienced neuro-interventionists, with one discussing with patients’ family members to acquire consent for thrombectomy, and the other preparing patients for thrombectomy |
| Green light route | Medical department decision in the best interest of the patient to whether thrombectomy could be performed in critical or emergency situations if a patient family member could be contacted |
| Surgery was provided without delays for hospital fees payment for all patients | |
| Prepare in advance | Preparation of the medications and required devices for thrombectomy in advance by an interventional nurse once the notification is received |
| Feedback | Holding monthly stroke meetings to analyze the etiology of DPT-delayed cases by hospital chief and the ED staff, neurology, and radiology department staff |
| Reward | Rewarding participation of intervention center, ED staff, neurology, and radiology departments financially if DPT was performed less than or equal to 120 min and if patient outcomes were above satisfactory level |
| Public education | Increasing the awareness of the public about the signs and symptoms of acute stroke and thrombectomy by using local newspapers, television programs and the Internet platform by Regional Health Bureau and Media Department of the hospital |
Abbreviations- CT Computerized tomography, CTA Computed tomography angiography, CTP Computed tomography perfusion, DPT Door-to-puncture time, ED Emergency department, MRA Magnetic resonance angiography, MRP Magnetic resonance perfusion
Clinical and imaging data for different phases of the study. P values are provided for each component
| Pre-intervention | Interim-intervention | Post-intervention | P | |
|---|---|---|---|---|
| Number | 14 | 39 | 45 | |
| Age, mean ± SD | 61.57 | 66.87 | 65.29 | 0.434 |
| Male, n, % | 11 (78.6%) | 30 (76.9%) | 31 (68.9%) | 0.643 |
| Hypertension, n, % | 6 (42.9%) | 24 (61.5%) | 30 (66.7%) | 0.679 |
| AF, n, % | 6 (42.9%) | 13 (33.3%) | 17 (37.8%) | 0.802 |
| DM, n, % | 1 (7.1%) | 6 (15.4%) | 11 (24.4%) | 0.284 |
| CAD, n, % | 4 (28.6%) | 9 (23.1%) | 9 (20.0%) | 0.792 |
| Previous Stroke, n, % | 1 (7.1%) | 10 (25.6%) | 9 (20.0%) | 0.336 |
| Dyslipidemia, n, %, | 1 (7.1%) | 5 (12.8%) | 9 (20.0%) | 0.434 |
| CKD, n, % | 0 (0.0%) | 3 (7.7%) | 7 (15.6%) | 0.193 |
| Smoker, n, % | 7 (50.0%) | 12 (30.8%) | 9 (20.0%) | 0.088 |
| mRS pre-treatment (IQR) | 0.0 (0.0,0.0) | 0.0 (0.0,0.0) | 0.0 (0.0,0.0) | 0.597 |
| pre-treatment ASPECTS (IQR) | 9.0 (8.0,9.0) | 8.0 (8.0,9.0) | 8.0 (7.5,9.0) | 0.184 |
| Admission NIHSS (IQR) | 19.0 (11.0,21.0) | 14.0 (11.0,18.0) | 17.0 (14.0,21.0) | 0.026 |
| Vessels occlusion | ||||
| ICA, n, % | 2 (14.3%) | 8 (20.5%) | 6 (13.3%) | 0.697 |
| M1, n, % | 5 (35.7%) | 16 (41.0%) | 22 (48.9%) | |
| M2, n, % | 0 (0.0%) | 1 (2.6%) | 0 (0.0%) | |
| Basilar artery, n, % | 5 (35.7%) | 8 (20.5%) | 14 (31.1%) | |
| Tandem, n, % | 2 (14.3%) | 6 (15.4%) | 3 (6.67%) | |
| TOAST type | ||||
| LAA, n, % | 3 (21.4%) | 22 (56.4%) | 19 (42.2%) | 0.028 |
| CE, n, % | 6 (42.9%) | 15 (38.5%) | 22 (51.2%) | |
| SVO, n, % | 0 (0.0%) | 1 (2.6%) | 0 (0.0%) | |
| SOE, n, % | 3 (21.4%) | 0 (0.0%) | 2 (4.4%) | |
| SUE, n, % | 2 (14.3%) | 1 (2.6%) | 2 (4.4%) | |
| IV Thrombolysis, n, % | 7 (50.0%) | 18 (46.2%) | 23 (51.1%) | 0.942 |
Abbreviations – AF Atrial fibrillation, DM Diabetes mellitus, CKD Chronic kidney disease, CAD Coronary heart disease, ICA Internal carotid artery, IV Intravenous, LAA Large-artery atherosclerosis, CE Cardioembolism, SOE Stroke of undetermined etiology, SUE Stroke of undetermined etiology, SVO Small vessel occlusion
Time metrics (min) for different phases of the study. P values are provided for each component. P1: P value for the pre-intervention vs Interim-intervention comparison. P2: P value for the pre-intervention vs post-intervention comparison. P3: P value for the interim-intervention vs post-intervention comparison
| Pre-intervention | Interim-intervention | post-intervention | P | P1 | P2 | P | |
|---|---|---|---|---|---|---|---|
| LKNPT(IQR) | 325.0 (301.0, 503.6) | 291.0 (220.0, 540.0) | 255.0 (186.5, 424.0) | 0. 048 | 0.686 | 0.060 | 0.372 |
| DPT(IQR) | 237.0 (203.8, 298.0) | 152.0 (105.0, 203.0) | 118.0 (98.0, 153.5) | 0.000 | 0.001 | 0.000 | 0.039 |
| DRT(IQR) | 338.0 (291.3, 407.3) | 243.0 (177.0, 322.0) | 206.0 (143.0, 238.0) | 0.000 | 0.014 | 0.000 | 0.019 |
| PRT(IQR) | 92.0 (57.5, 125.3) | 81.0 (52.0, 118.0) | 59.0 (40.5, 91.0) | 0.047 | 0.184 | 0.056 | 0.049 |
Abbreviations—LKNPT Last known normal-to-puncture time, DPT Door-to-puncture time, DRT Door-to-recanalization time, PRT puncture-to-recanalization time
Fig. 1Median LKNPT, DPT, DRT, and PRT (min) from 2018 to 2021. All measurements showed a decreasing trend across the study period
Target goal of DPT ≤ 120 min for different phases of the study. The P value is provided
| Door-to-puncture time (min) | Pre-intervention | Interim-intervention | Post-intervention | |
|---|---|---|---|---|
| DPT ≤ 120 min, n (%) | 1 (7.1%) | 13 (33.3%) | 24 (53.3%) | 0.006 |
Fig. 2The target goal of DPT ≤ 120 min showed consistent improvements over the study period
Comparison of patient outcomes at different phases of the study. P1: P value for the pre-intervention vs Interim-intervention comparison. P2: P value for the pre-intervention vs post-intervention comparison. P3: P value for the interim-intervention vs post-intervention comparison
| Pre-intervention, | Interim-intervention, | Post-intervention, | P | P1 | P2 | P3 | |
|---|---|---|---|---|---|---|---|
| Pneumonia, n, % | 6 (42.9%) | 16 (41.0%) | 15 (33.3%) | 0.702 | 0.905 | 0.516 | 0.466 |
| TICI post ≥ 2b, n, % | 11 (78.6%) | 34 (87.2%) | 37 (82.2%) | 0.709 | 0.440 | 0.759 | 0.531 |
| Urinary tract infection, n, % | 1 (9.1%) | 0 (0.0%) | 4 (8.9%) | 0.169 | 0.092 | 0.838 | 0.056 |
| sICH, n, %, | 5 (35.7%) | 6 (15.4%) | 4 (8.9%) | 0.052 | 0.108 | 0.015 | 0.359 |
| mRS discharge (IQR) | 4.0 (4.0,5.0) | 4.0 (2.0,5.0) | 3.0 (1.0,5.0) | 0.515 | 0.976 | 0.516 | 0.486 |
| Inpatient Mortality/hospice discharge, n, % | 3 (21.4%) | 9 (23.1%) | 10 (22.2%) | 0.991 | 0.899 | 0.095 | 0.926 |
| The favorable outcome at 3 months, n, % | 3 (21.4%) | 16 (41.0%) | 25 (55.6%) | 0.067 | 0.190 | 0.026 | 0.184 |
| Mortality at 3 months, n, % | 7 (50.0%) | 15 (38.5%) | 13 (28.9%) | 0.319 | 0.452 | 0.145 | 0.353 |
Outcome of different DPT (minutes). P1: P value for the pre-intervention vs Interim-intervention comparison. P2: P value for the pre-intervention vs post-intervention comparison. P3: P value for the interim-intervention vs post-intervention comparison
| DPT ≤ 120 | 120 < DPT ≤ 180 | DPT > 180 | P1 | P2 | P3 | |
|---|---|---|---|---|---|---|
| MRS (0–2), % | 21 (55.3%) | 12 (44.4%) | 11 (33.3%) | 0.390 | 0.064 | 0.379 |
| MRS (3–6), % | 17 (44.7%) | 15 (55.6%) | 22 (66.7%) | 0.390 | 0.064 | 0.379 |
P1: DPT ≤ 120 vs 120 < DPT ≤ 180; P2: DPT ≤ 120 vs DPT > 180; P3: 120 < DPT ≤ 180 vs DPT > 180